[1]
Bilovol , O. , Kniazkova , I. , Zemlianitsyna , O. , Dunaieva , I. , Romanova , I., Kurilo , O. , Sinaiko , V. and Kravchun , N. 2021. Hepatic fibrosis as an additional risk factor for the development of cardiovascular disorders in patients with type 2 diabetes mellitus with non-alcoholic fatty liver disease. Medicni perspektivi. 26, 2 (Jun. 2021), 126–134. DOI:https://doi.org/10.26641/2307-0404.2021.2.234639.